Biological

Peru 15 clinical trials

Also written CholeraGarde®.

studies test it: 3
open now: 0
in phase 3: 0
first study started: 2008

How each study uses Peru 15 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States: Not in FDA's approval records
European Union: Not in EMA's list of EU-wide authorisations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Brand

CholeraGarde®: 2

Studies by the year they started

3 studies that test it; most in 2008 (2)

Studies that test Peru 15, by start year
Year	Studies
2008	2
2010	1

By phase

A phase 1/2 study counts in both.

Phase 1: 1
Phase 2: 2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Cholera: 3

Who runs them

Industry 0 · Other 3

International Vaccine Institute (2) · National Institute of Allergy and Infectious Diseases (NIAID) (1)

Studies

Open first, then newest update. How each study uses Peru 15 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.